tiprankstipranks
Trending News
More News >

Jason Alan Carroll Insider Profile

4 Followers
Jason Alan Carroll, Chief Executive Officer at Tryptamine Therapeutics, holds 52.30M shares in Tryptamine Therapeutics (Ticker: AU:ENP), holds 32.07M shares in Island Pharmaceuticals Ltd (Ticker: AU:ILA). Most recently, Jason Alan Carroll ― shares of Tryptamine Therapeutics on ― for an estimated value of ―.
tipranks
Jason Alan Carroll

Jason Alan Carroll
Tryptamine Therapeutics (ENP)
Chief Executive Officer

Not Ranked
Jason Alan Carroll has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$19M
90.78%
9.22%
A breakdown of Jason Alan Carroll's holdings

Insider Roles

Island Pharmaceuticals Ltd
(ILA)
Director, Ten Percent Owner
Tryptamine Therapeutics
(ENP)
Chief Executive Officer
Roles that Jason Alan Carroll holds in companies

Most Profitable Insider Trade

Stock:
Island Pharmaceuticals Ltd
(ILA)
Rating:Informative Buy
Date:Jul 25, 2025 - Today
Return:+253.30%
The most profitable trade made by Jason Alan Carroll

Jason Alan Carroll's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tryptamine Therapeutics
Chief Executive Officer
AU$1.73M
Island Pharmaceuticals Ltd
Dec 03, 2025
Director, Ten Percent Owner
Uninformative Sell
68.25K
AU$17.00M
List of latest transactions for each holding click on a transaction to see Jason Alan Carroll's performance on stock

Jason Alan Carroll insider profile FAQ

What is the percentage of profitable transactions made by Jason Alan Carroll?
The percentage of profitable transactions made by Jason Alan Carroll is ―.
    What is the average return per transaction made by Jason Alan Carroll?
    The average return per transaction made by Jason Alan Carroll is ―.
      What stocks does Jason Alan Carroll hold?
      Jason Alan Carroll holds: AU:ENP, AU:ILA stocks.
        What was Jason Alan Carroll’s latest transaction?
        Jason Alan Carroll latest transaction was an Uninformative Buy of ―.
          What was Jason Alan Carroll's most profitable transaction?
          Jason Alan Carroll’s most profitable transaction was an Informative Buy of AU:ILA stock on July 25, 2025. The return on the trade was 253.30%.
            What is Jason Alan Carroll's role in Tryptamine Therapeutics?
            Jason Alan Carroll's role in Tryptamine Therapeutics is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.